Preferred Name |
Ipratropium Bromide Anhydrous |
|
Synonyms |
|
|
Definitions |
The bromide salt form of anhydrous ipratropium, a synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the actions of acetylcholine at parasympathetic, postganglionic, effector-cell junctions. When inhaled, ipratropium binds competitively to cholinergic receptors in the bronchial smooth muscle thereby blocking the bronchoconstrictor actions of the acetylcholine mediated vagal impulses. Inhibition of the vagal tone leads to dilation of the large central airways resulting in bronchodilation. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C170538 |
|
CAS_Registry |
22254-24-6 |
|
Chemical_Formula |
C20H30NO3.Br |
|
code |
C170538 |
|
Contributing_Source |
FDA |
|
definition |
The bromide salt form of anhydrous ipratropium, a synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the actions of acetylcholine at parasympathetic, postganglionic, effector-cell junctions. When inhaled, ipratropium binds competitively to cholinergic receptors in the bronchial smooth muscle thereby blocking the bronchoconstrictor actions of the acetylcholine mediated vagal impulses. Inhibition of the vagal tone leads to dilation of the large central airways resulting in bronchodilation. |
|
FDA_UNII_Code |
VJV4X1P2Z1 |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset | ||
label |
Ipratropium Bromide Anhydrous |
|
Legacy Concept Name |
Ipratropium_Bromide |
|
NCI_META_CUI |
CL1382973 |
|
Preferred_Name |
Ipratropium Bromide Anhydrous |
|
prefixIRI |
NCIT:C170538 |
|
prefLabel |
Ipratropium Bromide Anhydrous |
|
Semantic_Type |
Pharmacologic Substance |
|
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C170538 | NCIT | LOOM | |
http://purl.bioontology.org/ontology/RXNORM/1445143 | RXNORM | LOOM | |
http://purl.bioontology.org/ontology/SNOMEDCT/763205002 | SNOMEDCT | LOOM |